Heart Failure
Filter
Product price
Product categories
Conditions
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
Related Articles
Cardiovascular
SGLT2 Inhibitors in Heart Failure Care: A Practical Guide
Key TakeawaysClass impact: SGLT2 inhibitors reduce heart failure hospitalizations across ejection fractions.Mechanisms: Osmotic diuresis, natriuresis, and renal effects support hemodynamic stability.Who benefits: Patients with and without diabetes, especially with chronic…
Cardiovascular
Dapagliflozin for Heart Failure: Real-World Flow Outcomes
Dapagliflozin for heart failure has moved from trial evidence to everyday practice. Real-world data suggest consistent benefits across varied patients, including those with complex hemodynamics. This update places new findings…
Cardiovascular, Diabetes, Type
Pioglitazone and Heart Failure: Evidence, Risks, and Uses
Pioglitazone is a thiazolidinedione (TZD) used to improve insulin sensitivity in type 2 diabetes. Its brand name is Actos. Interest in cardiometabolic effects has grown, but Pioglitazone and heart failure…
Cardiovascular
Jardiance for Heart Failure: A Practical Benefits–Risks Guide
Used correctly, Jardiance for Heart Failure may reduce hospital stays and ease symptoms. This overview explains how the drug works, who benefits most, and what to watch for over time.…